$13.10-2.23 (-14.58%)
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.
Picard Medical, Inc. in the Healthcare sector is trading at $13.10 with a market capitalization of $22M. The stock is currently near its 52-week low of $2.65, remaining 59.4% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 79 is overbought against a weak tape. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.95Mβ | $1.15Mβ | $1.01Mβ | $1.19Mβ | $2.13M |
| Gross Profit | $616,000β | $275,000β | $411,000β | -$130,000β | -$127,000 |
| Operating Income | -$4.63Mβ | -$4.51Mβ | -$3.00Mβ | -$3.49Mβ | -$3.52M |
| Net Income | -$5.66Mβ | -$7.62Mβ | -$4.29Mβ | -$10.43Mβ | -$6.72M |
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to ...